Company intelligence / Profile preview

Ally Bridge Group

New York, New York, United Statesally-bridge.com ↗

Ownership: Private
Employees: ~35
Development stage: Other

Overview

Ally Bridge Group does not conduct clinical trials directly but invests in life science and healthcare innovation globally. Its investments span medtech, biotech, drug discovery, medical devices, and health research sectors. Portfolio companies are active in various clinical stages.

Industry: Investors

Partnerships

LifeTech Scientific Corporation (strategic partnership focused on medtech commercialization in China)WuXi PharmaTech/WuXi AppTec (investment consortium partner)

Beyond the preview

Go deeper on Ally Bridge Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ally Bridge Group.

Explore the full profile